Jane Street’s Edgewise Therapeutics EWTX Stock Holding History

Jane Street’s Portfolio EWTX Stock Details EWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$589K	Buy	14,500 +800	+6%	+$27.6K	﹤0.01%	7649
2026 Q1	$432K	Sell	13,700 -17,600	-56%	-$508K	﹤0.01%	8397
2025 Q4	$777K	Buy	+31,300	New	+$628K	﹤0.01%	6697
2025 Q2	–	Sell	-151,600	Closed	-$3.34M	–	9962
2025 Q1	$3.34M	Buy	151,600 +71,300	+89%	+$1.87M	﹤0.01%	3562
2024 Q4	$2.14M	Sell	80,300 -299,300	-79%	-$9.53M	﹤0.01%	3988
2024 Q3	$10.1M	Buy	+379,600	New	+$7.55M	﹤0.01%	1905

Other funds holding EWTX

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jane Street's EWTX Position: Q2 2026 in Review

Jane Street reduced its Edgewise Therapeutics (EWTX) stake by 16% in Q2 2026, selling an estimated $195K and leaving 29,934 shares worth $1.22M. The position accounts for ﹤0.01% of the portfolio, ranked #6126.

Jane Street first reported a position in EWTX in Q2 2022 and has held it in 15 quarters since. The position peaked at $1.34M in Q3 2024. 226 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.

Jane Street held 29,934 shares of Edgewise Therapeutics worth $1.22M as of Q2 2026.
Jane Street sold 5,644 Edgewise Therapeutics shares in Q2 2026, an estimated $195K.
Edgewise Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #6126 holding.
Jane Street first reported a position in Edgewise Therapeutics in Q2 2022 and has held it in 15 quarters since.
Jane Street's Edgewise Therapeutics position peaked at $1.34M in Q3 2024.
226 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.